MK

Mamta Kapoor

Active Director Director DIN 02201493
DIN 02201493 First appointment Oct 1993 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 1993
Shareholding value •••• Premium profile

About Mamta Kapoor

Data last updated:

Mamta Kapoor is a Director at Ceedar Pharmaceuticals Private Limited (since 1993). The company operates in Pharma. Ceedar Pharmaceuticals Private Limited reported revenue of ₹27.6 Lakh (FY 2025).

DIN 02201493
Primary Designation Director
Industry Pharma
First Appointment 26 Oct 1993
Oldest Company Age 32 yrs
Largest company Ceedar Pharmaceuticals Private Limited · ₹27.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Oct 19931993₹27.6 Lakh (FY 2025)Active

Board colleagues of Mamta Kapoor

NameDINCompanyDesignation
Anil Kumar Kapoor02194069Ceedar Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ceedar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mamta Kapoor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta Kapoor

Mamta Kapoor currently holds 1 directorship: Ceedar Pharmaceuticals Private Limited (Director, since 26 Oct 1993, revenue ₹27.6 Lakh (FY 2025)).

Mamta Kapoor was first appointed on 26 Oct 1993 as Director at Ceedar Pharmaceuticals Private Limited.

The current boards of Mamta Kapoor's companies include Anil Kumar Kapoor (Ceedar Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available